Clinical trial
Clinical Performance Evaluation of SARS-CoV-2 Antigen Assay in Point of Care Settings
NCT05213897 is registered in ClinicalTrials.gov with Freedom For All Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Performance Evaluation of SARS-CoV-2 Antigen Assay in Point of Care Settings
- Lead sponsor
- Freedom For All Diagnostics
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 27, 2022
- Completion date
- June 1, 2022
- Enrollment
- 232 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.